For: | Sgouros J, Cast J, Garadi KK, Belechri M, Breen DJ, Monson JR, Maraveyas A. Chemotherapy plus percutaneous radiofrequency ablation in patients with inoperable colorectal liver metastases. World J Gastrointest Oncol 2011; 3(4): 60-66 [PMID: 21528091 DOI: 10.4251/wjgo.v3.i4.60] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v3/i4/60.htm |
Number | Citing Articles |
1 |
Andreas H. Mahnken, Thierry de Baère. Locoregional Tumor Therapy. 2015; : 141 doi: 10.1007/978-3-642-36572-0_10
|
2 |
Andreas H. Mahnken, Thierry de Baère. Locoregional Tumor Therapy. 2018; : 215 doi: 10.1007/978-3-319-69947-9_9
|
3 |
Ky Thai Doan, Long Nguyễn Việt, Thinh Nguyen Tien, Binh Nguyen Canh, Hoai Ngo Thi, Ngoc Nguyen Thanh, Bieu Bui Quang, Quang Le Van, Hyun Woong Lee, Bang Mai Hong, Dirk Uhlmann. Prognostic Factors of Radiofrequency Ablation plus Systemic Chemotherapy for Unresectable Colorectal Cancer with Liver Metastasis. International Journal of Hepatology 2020; 2020: 1 doi: 10.1155/2020/8836922
|
4 |
H. Jin, A. Chalkidou, M. Hawkins, J. Summers, S. Eddy, J.L. Peacock, B. Coker, M.R. Kartha, J. Good, M. Pennington, A. Baker, L. Berry, M. Hatton, A. Henry, J. Lee, R. Patel, H. Powell, S. Sahdra, N. Slevin, N. Van As, G. Webster, L. Zou. Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiation Therapy Compared With Surgery and Radiofrequency Ablation in Two Patient Cohorts: Metastatic Liver Cancer and Hepatocellular Carcinoma. Clinical Oncology 2021; 33(3): e143 doi: 10.1016/j.clon.2020.08.010
|
5 |
Hayeon Kim, Beant Gill, Sushil Beriwal, M. Saiful Huq, Mark S. Roberts, Kenneth J. Smith. Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy Compared With Radiofrequency Ablation for Inoperable Colorectal Liver Metastases. International Journal of Radiation Oncology*Biology*Physics 2016; 95(4): 1175 doi: 10.1016/j.ijrobp.2016.02.045
|
6 |
Thomas J. Vogl, Parviz Farshid, Nagy N. N. Naguib, Abbas Darvishi, Babak Bazrafshan, Emmanuel Mbalisike, Thorsten Burkhard, Stephan Zangos. Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies. La radiologia medica 2014; 119(7): 451 doi: 10.1007/s11547-014-0415-y
|
7 |
Klaas M. Govaert, Charlotte S. van Kessel, Martijn Lolkema, Theo J. M. Ruers, Inne H. M. Borel Rinkes. Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases?. Current Colorectal Cancer Reports 2012; 8(2): 130 doi: 10.1007/s11888-012-0122-9
|
8 |
Ayumi Hamada, Koichiro Yamakado, Atsuhiro Nakatsuka, Junji Uraki, Masataka Kashima, Haruyuki Takaki, Takashi Yamanaka, Yasuhiro Inoue, Masato Kusunoki, Kan Takeda. Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates. Japanese Journal of Radiology 2012; 30(7): 567 doi: 10.1007/s11604-012-0089-0
|
9 |
Bibin Prasad, Jung Kyung Kim, Suzy Kim. Role of Simulations in the Treatment Planning of Radiofrequency Hyperthermia Therapy in Clinics. Journal of Oncology 2019; 2019: 1 doi: 10.1155/2019/9685476
|
10 |
Andreas H. Mahnken, Philippe L. Pereira, Thierry de Baère. Interventional Oncologic Approaches to Liver Metastases. Radiology 2013; 266(2): 407 doi: 10.1148/radiol.12112544
|